0

Antacids Market by Type and Geography - Forecast and Analysis 2022-2026

  • Published: Mar 2022
  • Pages: 129
  • SKU: IRTNTR72909
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The antacids market share is expected to increase to USD 712.45 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 3.37%.

This antacids market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers antacids market segmentation by type (non-symmetric antacids and symmetric antacids) and geography (North America, Europe, Asia, and Rest of World (ROW)).

What will the Antacids Market Size be During the Forecast Period?

Antacids Market Size

Download the Free Report Sample to Unlock the Antacids Market Size for the Forecast Period and Other Important Statistics

 

The antacids market report also offers information on several market vendors, including Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., and The Procter and Gamble Co. among others.

Parent Market Analysis

Technavio categorizes the global antacid market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the antacids market during the forecast period.

Who are the Major Antacids Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Advance Pharmaceutical Inc.
  • AmerisourceBergen Corp.
  • Bayer AG
  • Cardinal Health Inc.
  • GlaxoSmithKline Plc
  • Humco Holding Group Inc.
  • iNova Pharmaceuticals
  • Johnson and Johnson
  • Neogen Corp.
  • Novartis AG
  • NuCare Laboratories India
  • Pfizer Inc.
  • Pharmaceutical Associates Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • United Natural Foods Inc.
  • WellSpring Pharmaceutical Corp.
  • The Procter and Gamble Co.

 

This statistical study of the antacids market encompasses successful business strategies deployed by the key vendors. The antacids market is fragmented and the vendors are deploying growth strategies such as R and D and technological innovation to compete in the market.

Product Insights and News

  • AmerisourceBergen Corp. - The company offers antacids that are naturally made water dissolving formula to cure acidity and heartburn, under the brand name of American Health Packaging.
  • AmerisourceBergen Corp. - Under the pharmaceutical distribution services segment, the company offers various products including pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and related equipment and services to various healthcare providers.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The antacids market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Antacids Market: Key Drivers, Trends, and Challenges

The rising geriatric population is notably driving the antacids market growth, although factors such as adverse effect of prolonged use of antacids may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the antacids industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Antacids Market Driver

One of the key factors driving the global antacids market growth is the rising geriatric population. With age, the sphincter in the lower esophagus tends to relax, which allows acid to reflux or flow backward, causing heartburn. Heartburn can also be caused by GERD. Age is directly related to the increase in various disorders, including GERD. Furthermore, advances in healthcare and advanced treatment options for various diseases have increased the average life expectancy of people. For instance, as per the US census bureau, in 2015, people aged 65 years and above were approximately 617 million, and the number is expected to reach 1,566 million by 2050. As per data collected by the World Bank and the NIH, the percentage of the aging population is expected to grow from 8.48% in 2016 to approximately 17% by 2050. Thus, such factors are expected to drive market growth in the forecast period.

Key Antacids Market Trend

Growing e-commerce market is one of the key antacids market trends that is expected to impact the industry positively in the forecast period. The global antacids market sees an increasing trend of online transactions as the market is dominated by OTC drugs that require no prescription. The major reason for the increased popularity of e-commerce retailing has been the retailers' efforts on improving the online shopping experience through better online education and targeted marketing. The strong viability of e-commerce channels further stimulates the sales of antacids. Online retailers also offer free access to various online offers. For instance, Amazon offers the option of different billing and shipping addresses, which helps the customer to send medication needed to a different geographic location easily. Such online facilities encourage consumers to buy medicines online, thereby stimulating market growth.

Key Antacids Market Challenge

One of the key challenges to the global antacids market growth is the adverse effect of prolonged use of antacids. Many antacids such as Maalox, Mylanta, Rolaids, and TUMS contain calcium. If these are taken in high doses, patients could be at risk of calcium overdose, which can lead to adverse effects such as nausea, kidney stones, and swelling of the feet. Antacids that consist of aluminum hydroxide may cause constipation, aluminum intoxication, osteocalcin, and hypophosphatemia. The availability of OTC antacids and their combined use with other medications can result in drug-drug interactions and have serious side effects. For instance, antacids, when taken with acidic drugs such as digoxin or chlorpromazine, can result in drug absorption due to which the concentration of the drug in the blood becomes low, which further reduces the efficacy of the drug. Such adverse effects of antacids can hamper the growth of the market.

This antacids market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Which are the Key Regions for Antacids Market?

Antacids Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

41% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for antacids in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The high prevalence of GERD for which antacids are predominantly used, the increasing preference for OTC medications, and the practice of self-medication among the population will facilitate the antacids market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

Countries across North America were severely affected by the COVID-19 pandemic in 2020. The rise in the incidence of COVID-19 in countries across North America influenced governments to introduce emergency legislation, which included restrictions on several business activities. This led to the shutdown of manufacturing units of several industries. In the first few months of 2020, most pharmaceutical companies focused on developing vaccines and manufacturing drugs to support the medical crisis associated with COVID-19, reducing the production volume of antacids. This resulted in the slow growth of the market in North America. However, to support the sale of nonprescription or OTC drugs in March 2020, the American President, Joe Biden, signed the Coronavirus Aid Relief and Economic Security (CARES) Act (HR 748). Other factors such as the rising R and D expenditure by pharmaceutical companies in 2021 are expected to positively influence the antacids market growth in North America during the forecast period.

Antacids Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the antacids market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

What are the Revenue-generating Type Segments in the Antacids Market?

Antacids Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The antacids market share growth by the non-systemic antacid segment will be significant during the forecast period. The non-systemic antacids segment is expected to grow at a moderate rate in the coming years owing to better efficacy demonstrated when used in combination. In addition, the drugs used as combination therapies minimize the adverse effects and effectively treat GERD and acid reflux.

This report provides an accurate prediction of the contribution of all the segments to the growth of the antacids market size and actionable market insights on post COVID-19 impact on each segment.

 

Antacids Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 3.37%

Market growth 2022-2026

$ 712.45 million

Market structure

Fragmented

YoY growth (%)

3.11

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 41%

Key consumer countries

US, Canada, Brazil, Germany, and UK

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., and The Procter and Gamble Co.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Antacids Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive antacids market growth during the next five years
  • Precise estimation of the antacids market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the antacids industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of antacids market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Type

    • 5.1 Market segments
      • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
    • 5.2 Comparison by Type
      • Exhibit 26: Chart on Comparison by Type
      • Exhibit 27: Data Table on Comparison by Type
    • 5.3 Non-symmetric antacids - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
    • 5.4 Symmetric antacids - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Symmetric antacids - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Symmetric antacids - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Type
      • Exhibit 36: Market opportunity by Type ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 Canada - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.10 UK - Market size and forecast 2021-2026
      • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.11 Brazil - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Brazil - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 AmerisourceBergen Corp.
              • Exhibit 85: AmerisourceBergen Corp. - Overview
              • Exhibit 86: AmerisourceBergen Corp. - Business segments
              • Exhibit 87: AmerisourceBergen Corp. - Key offerings
              • Exhibit 88: AmerisourceBergen Corp. - Segment focus
            • 10.4 Bayer AG
              • Exhibit 89: Bayer AG - Overview
              • Exhibit 90: Bayer AG - Business segments
              • Exhibit 91: Bayer AG - Key offerings
              • Exhibit 92: Bayer AG - Segment focus
            • 10.5 Cardinal Health Inc.
              • Exhibit 93: Cardinal Health Inc. - Overview
              • Exhibit 94: Cardinal Health Inc. - Business segments
              • Exhibit 95: Cardinal Health Inc. - Key news
              • Exhibit 96: Cardinal Health Inc. - Key offerings
              • Exhibit 97: Cardinal Health Inc. - Segment focus
            • 10.6 GlaxoSmithKline Plc
              • Exhibit 98: GlaxoSmithKline Plc - Overview
              • Exhibit 99: GlaxoSmithKline Plc - Business segments
              • Exhibit 100: GlaxoSmithKline Plc - Key news
              • Exhibit 101: GlaxoSmithKline Plc - Key offerings
              • Exhibit 102: GlaxoSmithKline Plc - Segment focus
            • 10.7 Humco Holding Group Inc.
              • Exhibit 103: Humco Holding Group Inc. - Overview
              • Exhibit 104: Humco Holding Group Inc. - Product / Service
              • Exhibit 105: Humco Holding Group Inc. - Key offerings
            • 10.8 Johnson and Johnson
              • Exhibit 106: Johnson and Johnson - Overview
              • Exhibit 107: Johnson and Johnson - Business segments
              • Exhibit 108: Johnson and Johnson - Key news
              • Exhibit 109: Johnson and Johnson - Key offerings
              • Exhibit 110: Johnson and Johnson - Segment focus
            • 10.9 Novartis AG
              • Exhibit 111: Novartis AG - Overview
              • Exhibit 112: Novartis AG - Business segments
              • Exhibit 113: Novartis AG - Key offerings
              • Exhibit 114: Novartis AG - Segment focus
            • 10.10 Sanofi SA
              • Exhibit 115: Sanofi SA - Overview
              • Exhibit 116: Sanofi SA - Business segments
              • Exhibit 117: Sanofi SA - Key news
              • Exhibit 118: Sanofi SA - Key offerings
              • Exhibit 119: Sanofi SA - Segment focus
            • 10.11 Sun Pharmaceutical Industries Ltd.
              • Exhibit 120: Sun Pharmaceutical Industries Ltd. - Overview
              • Exhibit 121: Sun Pharmaceutical Industries Ltd. - Product / Service
              • Exhibit 122: Sun Pharmaceutical Industries Ltd. - Key offerings
            • 10.12 WellSpring Pharmaceutical Corp.
              • Exhibit 123: WellSpring Pharmaceutical Corp. - Overview
              • Exhibit 124: WellSpring Pharmaceutical Corp. - Product / Service
              • Exhibit 125: WellSpring Pharmaceutical Corp. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 126: Inclusions checklist
                • Exhibit 127: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 128: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 129: Research methodology
                • Exhibit 130: Validation techniques employed for market sizing
                • Exhibit 131: Information sources
              • 11.5 List of abbreviations
                • Exhibit 132: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Antacids Market market growth will increase by $712.45 mn during 2022-2026.
              The antacids market market is expected to grow at a CAGR of 3.37% during 2022-2026.
              Technavio has segmented the antacids market market by type (Non-symmetric antacids and Symmetric antacids) and geography (North America, Europe, Asia, and Rest of World (ROW)).
              Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., The Procter and Gamble Co. are a few of the key vendors in the antacids market market.
              North America will register the highest growth rate of 41% among the other regions. Therefore, the antacids market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the antacids market market growth are:
              • Rising geriatric population
              • Growing e-commerce market
              The antacids market market vendors should focus on grabbing business opportunities from the non-symmetric antacids segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>